Online Pharmacy Medicine Blog

Last week, Sen. Byron Dorgan a Democrat from North Dakota introduced a piece of legislation that would save consumers over a $100 billion dollars by allowing them to order their drugs from several other countries.

According to the Bangor Daily News

a North Dakota Democrat, introduced legislation to allow consumers to buy drugs from several other countries. As a safeguard, only medication approved by the U.S. Food and Drug Administration and produced in facilities approved by the FDA could be purchased by U.S. residents. The measure was co-sponsored by Sen. Olympia Snowe.

Sen. Dorgan estimated the legislation would save consumers about $100 billion over the next decade.

The article goes on to say the only thing stopping the legislation is the FDA and PhRMA. The FDA won’t support the importation of drugs because they are protecting the pockets of the big pharmaceutical companies, and PhRMA is the pharmaceutical companies lobbying group.

Senators have verified that the drugs are safe, the only hold up is they don’t want YOU to save money on your prescriptions. The good news is you don’t have to wait on them. You can order the medications you need like Actos and Lexapro right now.

Don’t let lobbyists and bureaucrats to decide when you can save money on your prescription medication, join ePharmacies.com today.

A growing stream of studies and news reports is questioning the effectiveness of Abilify (aripiprazole), the heavily advertised antidepressant.

As the Clinical Psychology and Psychiatry blog reports:

Yet another Abilify for depression study is out in CNS Spectrums and guess what… Still not a significant advantage over placebo according to patients. So in each of three large studies, Abilify has failed to beat a placebo according to patients’ self-report. These three trials are the basis for the massive marketing campaign and an FDA approval.

Abilify started off as an also-ran antipsychotic. But times have changed. Bristol-Myers Squibb’s CEO prophetically stated in 2004 after Abilify’s approval as a treatment for bipolar disorder: “This approval underscores our commitment to delivering innovative solutions that address unmet needs for a broad spectrum of patients with mental illness, as well as their families and health care providers.”

He could as easily have stated: “This approval underscores our commitment to rebranding our unpopular antipsychotic as a Swiss Army Knife/broad spectrum psychotropic that treats everything under the sun. If I can get the FDA and the public to believe that this akathisia-inducing bottom feeder can treat depression, then I’ll be LOADED, BWAAH, HA HA HA HA!!!”

The Los Angeles Times has written of Abilify:

Mounting research has made clear that the atypical antipsychotics [such as Abilify] are not only less safe than originally thought; they are not, on balance, any safer or more effective than older drugs for schizophrenia. And for the population of depressed or anxious patients that some are now proposed to treat, studies suggest the benefits are extremely modest.

Abilify has been specifically advertised as an “add-on” antidepressant for people who are currently taking antidepressants — but who still feel depressed. As such, hordes of patients have gone to their doctors and psychiatrists asking if they should add Abilify to their drug regimen.

As always, consult with your doctor. But it would seem a prudent course to try a number of different conventional antidepressants (Lexapro, Wellbutrin, etc.) before concluding that you need to take not one, but two, drugs for your depression.